ArticleJugan geon-gang gwa jilbyeong2023
[The Suspected SARS-CoV-2 Reinfection Rate and Risk Factors in Daegu-Gyeongbuk Region].
Article in Jugan geon-gang gwa jilbyeong, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Daegu-Gyeongbuk has experienced an upsurge in cases of SARS-CoV-2 reinfections that have been attributed to the Omicron. In preparation for implementing preventative and control measures against reinfections, a study was conducted to analyze the incidence of suspected SARS-CoV-2 reinfections and the associated risk factors among patients with coronavirus disease 2019 (COVID-19), reported in Daegu-Gyeongbuk, from January 20, 2020, to December 31, 2022. The suspected SARS-CoV-2 reinfection rate in the region was 3.25% from the first suspected case in May 2021 until December 30, 2022. Notably, during the final four weeks of 2022 (4-31 December), the suspected SARS-CoV-2 reinfection rate increased to 13.60%. The study results indicated that the 6-11- and 12-17-year age groups (i.e., school students) had 1.65 times and 1.96 times higher risk of SARS-CoV-2 reinfection, respectively, compared with that in the 18-49-year age group. The at-risk elderly population, aged 60 years and above, also demonstrated a 1.19 times higher risk of SARS-CoV-2 reinfection than that in the 18-49-year age group. Additionally, the risk of SARS-CoV-2 reinfection decreased by 58% for fully vaccinated individuals, 40% for those vaccinated with the first booster, and 51% for those vaccinated with a third booster, compared with the risk in unvaccinated individuals. In conclusion, this study underscores the importance of regular administration of COVID-19 vaccines that have been modified according to the variants for school-aged children and elderly individuals aged 60 and above.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.